Medicines Co (MDCO) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Income from operations: -75.74M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Financial Fact:
Income from operations: -75.74M
Today's EPS Names:
BNCC, ZVOI, SYRS, More
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q2 non-GAAP EPS of $0.24, $0.04 better than the analyst estimate of $0.20. Revenue for the quarter came in at $119.6 million versus the consensus estimate of $117.66 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
